These are the stocks posting the largest moves before the bell.Market Insiderread more
Allergan shareholders will receive 0.8660 AbbVie shares and $120.30 in cash for each share held, for a total value of $188.24 per Allergan share.Biotech and Pharmaceuticalsread more
Amazon announces that Amazon Prime Day will last for two days, starting July 15.Technologyread more
Home prices in April were 3.5% higher than a year earlier, according to the S&P CoreLogic Case-Shiller U.S. National Home Price Index.Real Estateread more
Joe Biden could face some uncomfortable questions about his record on women this week at the first Democratic presidential debates in Miami.2020 Electionsread more
"What else do you have to do that will actually have to affect the Iranians' calculus?" said Amos Hochstein, who served as U.S. special envoy for international energy affairs...World Politicsread more
FedEx heads into Tuesday afternoon's earnings deep in a bear market. A failure to deliver could mark a massive buying opportunity.Trading Nationread more
Investors are piling into gold, sending the precious metal to a six-year high on Monday, and analysts think the commodity has established a base to go even higher.Marketsread more
Here are the biggest calls on Wall Street on TuesdayInvestingread more
Gold prices hit their highest level in six years on Tuesday as investors plowed into the precious metal amid the prospects of lower interest rates and tensions between Iran...Marketsread more
In a new interview with CBS's Gayle King, Adam Mosseri addressed a common suspicion about how Instagram targets ads.Technologyread more
More new shorts were added in Nasdaq stocks in the end of March, but short interest declined on NYSE-listed names.
After hitting a two year high earlier in the year, short interest in NYSE stocks declined in the second half of March for the first time in 10 weeks.
Stocks listed on NASDAQ,however, saw an increase of 1.91 percent during the same period. As of March end, short interest rose to about 7.67 billion shares, compared with 7.53 billion shares as of mid-March.
The NYSE reported on Monday that short interest declined to 14.5 billion shares for the final weeks of March from 14.6 billion on March 14, a 1.05 percent decrease – the biggest such decrease since December of last year.
Biotech was one of the biggest shorts. Stocks with some of the highest ratios on Nasdaq were Myriad Genetics, WorldAcceptance and Sodastream, with more than 30 percent of outstanding shares sold as short.
Short interest measures the total number of shares of a security that has been sold short, expressed as a percent of total tradeable shares.
Investors track short-interest levels to gain a sense of where a stock might be headed, along with some insight into whether any positive news might force short traders to cover their positions, pushing stocks higher.
- By CNBC's Pradip Sigdyal